Systematix Corporate [SYSTMTXC] vs Authum Investment [AIIL] Detailed Stock Comparison
Systematix Corporate
BSE
Loading...
Authum Investment
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Systematix Corporate wins in 4 metrics, Authum Investment wins in 16 metrics, with 0 ties. Authum Investment appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Systematix Corporate | Authum Investment | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.76 | 13.26 | Authum Investment |
| Price-to-Book Ratio | 5.97 | 3.68 | Authum Investment |
| Debt-to-Equity Ratio | 6.76 | 7.18 | Systematix Corporate |
| PEG Ratio | 0.07 | -0.95 | Authum Investment |
| EV/EBITDA | 29.01 | 12.11 | Authum Investment |
| Profit Margin (TTM) | 37.77% | 93.88% | Authum Investment |
| Operating Margin (TTM) | 37.14% | 96.55% | Authum Investment |
| EBITDA Margin (TTM) | 37.14% | 96.55% | Authum Investment |
| Return on Equity | 15.26% | 28.87% | Authum Investment |
| Return on Assets (TTM) | 10.68% | 26.36% | Authum Investment |
| Free Cash Flow (TTM) | $-229.03M | $2.53B | Authum Investment |
| Dividend Yield | 0.09% | 0.06% | Systematix Corporate |
| 1-Year Return | -92.20% | 77.86% | Authum Investment |
| Price-to-Sales Ratio (TTM) | 12.32 | 12.45 | Systematix Corporate |
| Enterprise Value | $15.25B | $548.85B | Authum Investment |
| EV/Revenue Ratio | 10.57 | 12.61 | Systematix Corporate |
| Gross Profit Margin (TTM) | 56.99% | 97.25% | Authum Investment |
| Revenue per Share (TTM) | $11 | $256 | Authum Investment |
| Earnings per Share (Diluted) | $4.10 | $240.61 | Authum Investment |
| Beta (Stock Volatility) | 0.79 | -0.82 | Authum Investment |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Systematix Corporate vs Authum Investment Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Systematix Corporate | 3.90% | 4.25% | 13.53% | 23.41% | 7.01% | -25.79% |
| Authum Investment | 1.43% | 6.55% | 4.98% | 19.96% | 111.74% | 69.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Systematix Corporate | -92.20% | -48.22% | 268.12% | 724.19% | -2.88% | 1,726.14% |
| Authum Investment | 77.86% | 275.18% | 275.18% | 275.18% | 275.18% | 275.18% |
News Based Sentiment: Systematix Corporate vs Authum Investment
Systematix Corporate
News based Sentiment: POSITIVE
Systematix delivered exceptional Q1 results and secured a significant role in the Jaro Education IPO, signaling strong growth and diversification. While valuation remains high and search interest is declining, the overall narrative is positive, driven by robust financial performance and optimistic analyst forecasts.
Authum Investment
News based Sentiment: POSITIVE
October was a significant month for Authum Investment & Infrastructure Ltd. due to the combination of impressive financial results, a strategic move into the pharmaceutical sector, and continued positive sentiment from analysts and institutional investors. These developments collectively strengthen the investment case and suggest a positive trajectory for the company.
Performance & Financial Health Analysis: Systematix Corporate vs Authum Investment
| Metric | SYSTMTXC | AIIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹19.16B | ₹542.19B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 74,323 | 247,963 |
| 90 Day Avg. Volume | 54,322 | 219,497 |
| Last Close | ₹145.15 | ₹3,250.10 |
| 52 Week Range | ₹94.43 - ₹202.00 | ₹1,325.50 - ₹3,295.00 |
| % from 52W High | -28.14% | -1.36% |
| All-Time High | ₹2,021.00 (Oct 21, 2024) | ₹3,295.00 (Sep 16, 2025) |
| % from All-Time High | -92.82% | -1.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.32% | -0.15% |
| Quarterly Earnings Growth | 5.00% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.38% | 0.94% |
| Operating Margin (TTM) | 0.37% | 0.97% |
| Return on Equity (TTM) | 0.15% | 0.29% |
| Debt to Equity (MRQ) | 6.76 | 7.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹21.82 | ₹866.73 |
| Cash per Share (MRQ) | ₹19.42 | ₹21.74 |
| Operating Cash Flow (TTM) | ₹232.82M | ₹70.10B |
| Levered Free Cash Flow (TTM) | ₹457.61M | ₹42.41B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.09% | 0.06% |
| Last 12-Month Dividend | ₹0.11 | ₹1.50 |
Valuation & Enterprise Metrics Analysis: Systematix Corporate vs Authum Investment
| Metric | SYSTMTXC | AIIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.76 | 13.26 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.07 | -0.95 |
| Price to Sales (TTM) | 12.32 | 12.45 |
| Price to Book (MRQ) | 5.97 | 3.68 |
| Market Capitalization | ||
| Market Capitalization | ₹19.16B | ₹542.19B |
| Enterprise Value | ₹15.25B | ₹548.85B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.57 | 12.61 |
| Enterprise to EBITDA | 29.01 | 12.11 |
| Risk & Other Metrics | ||
| Beta | 0.79 | -0.82 |
| Book Value per Share (MRQ) | ₹21.82 | ₹866.73 |
Financial Statements Comparison: Systematix Corporate vs Authum Investment
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SYSTMTXC | AIIL |
|---|---|---|
| Revenue/Sales | ₹287.88M | ₹12.15B |
| Cost of Goods Sold | ₹123.83M | ₹334.70M |
| Gross Profit | ₹164.05M | ₹11.82B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹50.45M | ₹11.34B |
| EBITDA | ₹115.81M | ₹11.37B |
| Pre-Tax Income | ₹138.67M | ₹11.44B |
| Income Tax | ₹34.08M | ₹2.01B |
| Net Income (Profit) | ₹104.60M | ₹9.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SYSTMTXC | AIIL |
|---|---|---|
| Cash & Equivalents | ₹427.46M | ₹1.08B |
| Total Current Assets | ₹3.64B | ₹32.75B |
| Total Current Liabilities | ₹1.01B | ₹10.38B |
| Long-Term Debt | ₹94.67M | ₹3.60B |
| Total Shareholders Equity | ₹3.00B | ₹146.89B |
| Retained Earnings | ₹1.52B | ₹28.29B |
| Property, Plant & Equipment | ₹0 | ₹21.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SYSTMTXC | AIIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SYSTMTXC | AIIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 74,323 | 247,963 |
| Average Daily Volume (90 Day) | 54,322 | 219,497 |
| Shares Outstanding | 136.54M | 169.85M |
| Float Shares | 12.56M | 33.92M |
| % Held by Insiders | 0.85% | 0.84% |
| % Held by Institutions | 0.02% | 0.06% |
Dividend Analysis & Yield Comparison: Systematix Corporate vs Authum Investment
| Metric | SYSTMTXC | AIIL |
|---|---|---|
| Last 12-Month Dividend | ₹0.11 | ₹1.50 |
| Last 12-Month Dividend Yield | 0.09% | 0.06% |
| 3-Year Avg Annual Dividend | ₹0.04 | ₹0.50 |
| 3-Year Avg Dividend Yield | 0.03% | 0.04% |
| 3-Year Total Dividends | ₹0.12 | ₹1.50 |
| Ex-Dividend Date | Sep 12, 2025 | May 16, 2025 |